Latest Breaking News On - Biosimilar medicines - Page 1 : comparemela.com

Penetration rate of generic and biosimilar drugs in Tunisia estimated at 55%

Penetration rate of generic and biosimilar drugs in Tunisia estimated at 55%
tanzanianewsreports.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tanzanianewsreports.com Daily Mail and Mail on Sunday newspapers.

Mehdi dridiWorld health organisationWorld bankInternational nameInternational days of genericCentral pharmacyTunisia mehdi dridiInternational daysBiosimilar medicinesInternational non proprietary nameAgence tunis afrique presse

tap.info.tn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tap.info.tn Daily Mail and Mail on Sunday newspapers.

Mehdi dridiInternational days of genericInternational nameWorld bankWorld health organisationCentral pharmacyTunisia mehdi dridiInternational daysBiosimilar medicinesInternational non proprietary name

Samsung Bioepis Gains European Commission Approval For PYZCHIVA, a Biosimilar to Stelara (Ustekinumab)

Samsung Bioepis Gains European Commission Approval For PYZCHIVA, a Biosimilar to Stelara (Ustekinumab)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomDennis riedlSamsung bioepisSamsung bioepiByoungin jungRegulatory affairs team leaderEuropean commissionEuropean medicines agencySamsung bioepis co ltdVice presidentEuropean economic areaStelara productMedicines agencyBiosimilar medicinesAktien sie

Changes to drug patent rules could affect India s vast generic medicine industry, drive up costs

Amendments to the Patent Rules grant more power to patent holders and may lead to an increase in the cost of treatment of critical diseases.

South africaSouth africanNandita venkatesanBiswajit dharPhumeza tisileLeena menghaneyIndira gandhiClaudia martinezPaul barooahSupreme courtFrontieres access campaignWorld health assemblyIndian drug manufacturer associationMinistry of commerceGlobal drug facilityPatent rules

Clear opportunity for Indian pharma firms to improve medicine access globally: Report

Report assessed the efforts of major generic and biosimilar medicine manufacturers like Hikma, Teva Viatris, Cipla, and Sun Pharma in expanding access to their essential products in low- and middle-income countries

North yorkshireUnited kingdomJayasreek iyerTeva viatrisSun pharmaClaudia martResearch programmeDevelopment officeHarryb helmsley charitableAccess to medicine foundation genericBiosimilar medicines programmeDutch ministry of foreign affairsGeneric biosimilar medicines programmeAccess to medicine foundationMedicine foundationBiosimilar medicines